Androstenedione as a potential predictor of ovarian response in assisted reproductive technology programs
Aim. To assess the possibility of using androstenedione levels in blood serum and follicular fluid to predict ovarian response in assisted reproductive technology programs and to conduct a comparative analysis of the results obtained by 2 methods chemiluminescent immunoassay (CLIA) and high-perform...
Main Authors: | Anna G. Burduli, Natalia A. Kitsilovskaya, Yuliya V. Sukhova, Irina A. Vedikhina, Tatiana Yu. Ivanets, Vitaliy V. Chagovets, Nataliia L. Starodubtseva, Vladimir E. Frankevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2020-05-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/33968/21626 |
Similar Items
-
Follicular fluid and assisted reproductive technology programs outcomes (literature review)
by: Anna G. Burduli, et al.
Published: (2020-04-01) -
Hyperandrogenism by Liquid Chromatography Tandem Mass Spectrometry in PCOS: Focus on Testosterone and Androstenedione
by: Giorgia Grassi, et al.
Published: (2021-12-01) -
Changes in androstenedione, dehydroepiandrosterone, testosterone, estradiol, and estrone over the menopausal transition
by: Catherine Kim, et al.
Published: (2017-10-01) -
"Adulterated" Androstenedione: What FDA's Action against Andro Means for Industry
by: Collins Richard D, et al.
Published: (2004-05-01) -
Serum testosterone and androstenedione levels in cattle and rats at various ages and response of rats to human chorionic gonadotropin /
by: Singal, Sat Parkash
Published: (1974)